Active Ingredient/Content
|
Efficacy/Indication
- Initial monotherapy in patients ¡Ã2 yrs of age with partial onset or primary generalized tonic-clonic seizures.
- Adjunct therapy in patients ¡Ã2 yrs of age withpartial onset seizures or primary generalized
- tonic-clonic seizures and with seizures associated with Lennox-Gastaut syndrome. Migraine headache
- prophylaxis in adults.
|
Administration/Dosage
- Adults:
- Initial: Week 1: 25mg bid.
- Titrate: Week 2: 50mg bid. Week 3: 75mg bid. Week 4: 100mg bid. Week 5: 150mg bid. Week 6: 200mg bid.
|